Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 10


Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF.

Clin Cancer Res. 2014 Nov 1;20(21):5456-67. doi: 10.1158/1078-0432.CCR-14-0344. Epub 2014 Jun 3.


Resolution of novel human papillomavirus-induced warts after HPV vaccination.

Silling S, Wieland U, Werner M, Pfister H, Potthoff A, Kreuter A.

Emerg Infect Dis. 2014 Jan;20(1):142-5. doi: 10.3201/eid2001.130999.


Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.

Tota JE, Ramanakumar AV, Jiang M, Dillner J, Walter SD, Kaufman JS, Coutlée F, Villa LL, Franco EL.

Am J Epidemiol. 2013 Aug 15;178(4):625-34. doi: 10.1093/aje/kwt018. Epub 2013 May 9.


Therapy of human papillomavirus-related disease.

Stern PL, van der Burg SH, Hampson IN, Broker TR, Fiander A, Lacey CJ, Kitchener HC, Einstein MH.

Vaccine. 2012 Nov 20;30 Suppl 5:F71-82. doi: 10.1016/j.vaccine.2012.05.091. Review.


Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.

Daayana S, Elkord E, Winters U, Pawlita M, Roden R, Stern PL, Kitchener HC.

Br J Cancer. 2010 Mar 30;102(7):1129-36. doi: 10.1038/sj.bjc.6605611. Epub 2010 Mar 16.


Erythema multiforme following vaccination for human papillomavirus.

Katoulis AC, Liakou A, Bozi E, Theodorakis M, Alevizou A, Zafeiraki A, Mistidou M, Stavrianeas NG.

Dermatology. 2010;220(1):60-2. doi: 10.1159/000254898. Epub 2009 Nov 3.


The human papillomavirus vaccines.

Ljubojević S.

Acta Dermatovenerol Croat. 2006;14(3):208.


Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.

Vandepapeliere P, Barrasso R, Meijer CJ, Walboomers JM, Wettendorff M, Stanberry LR, Lacey CJ.

J Infect Dis. 2005 Dec 15;192(12):2099-107. Epub 2005 Nov 11.


Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination.

Moore RA, Nicholls PK, Santos EB, Gough GW, Stanley MA.

J Gen Virol. 2002 Sep;83(Pt 9):2299-301.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk